EP Patent

EP3509569A1 — Sterile injectable compositions comprising drug micelles

Assigned to Zydus Lifesciences Ltd · Expires 2019-07-17 · 7y expired

What this patent protects

The present invention relates to sterile injectable compositions comprising drug-phospholipid micelles. The present invention also relates to processes for the preparation of the sterile injectable compositions.

USPTO Abstract

The present invention relates to sterile injectable compositions comprising drug-phospholipid micelles. The present invention also relates to processes for the preparation of the sterile injectable compositions.

Drugs covered by this patent

Jevtana Kit (cabazitaxel) · Accord Hlthcare

Patent Metadata

Patent number: EP3509569A1
Jurisdiction: EP
Classification: —
Expires: 2019-07-17
Drug substance claim: No
Drug product claim: No
Assignee: Zydus Lifesciences Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.